Recursion Pharmaceuticals, Inc., is an innovative biotechnology company operating in the Pharmaceuticals industry in the United States of America. With a low Risk Rating Score of 13.9, the company is focused on integrating cutting-edge technologies in ESG fields such as biology, chemistry, automation, data science, and engineering. Their mission is to revolutionize drug discovery and enhance patient outcomes.